vs

Side-by-side financial comparison of ARBOR REALTY TRUST INC (ABR) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

ARBOR REALTY TRUST INC is the larger business by last-quarter revenue ($133.4M vs $87.2M, roughly 1.5× Schrodinger, Inc.). On growth, Schrodinger, Inc. posted the faster year-over-year revenue change (-1.2% vs -12.1%). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs -8.9%).

Arbor Realty Trust Inc. is a U.S.-headquartered specialized real estate investment trust (REIT). It primarily provides structured financing solutions for multifamily residential and commercial real estate projects, including bridge loans, agency lending, and mezzanine financing. Its core market covers the U.S. real estate sector, serving property owners, developers and real estate investors nationwide.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

ABR vs SDGR — Head-to-Head

Bigger by revenue
ABR
ABR
1.5× larger
ABR
$133.4M
$87.2M
SDGR
Growing faster (revenue YoY)
SDGR
SDGR
+10.8% gap
SDGR
-1.2%
-12.1%
ABR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
-8.9%
ABR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABR
ABR
SDGR
SDGR
Revenue
$133.4M
$87.2M
Net Profit
$32.5M
Gross Margin
65.7%
Operating Margin
-19.7%
Net Margin
37.3%
Revenue YoY
-12.1%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.08
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABR
ABR
SDGR
SDGR
Q4 25
$133.4M
$87.2M
Q3 25
$112.4M
$54.3M
Q2 25
$130.4M
$54.8M
Q1 25
$134.2M
$59.6M
Q4 24
$151.7M
$88.3M
Q3 24
$156.7M
$35.3M
Q2 24
$153.1M
$47.3M
Q1 24
$160.7M
$36.6M
Net Profit
ABR
ABR
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$52.0M
$-32.8M
Q2 25
$36.3M
$-43.2M
Q1 25
$43.4M
$-59.8M
Q4 24
$-40.2M
Q3 24
$73.5M
$-38.1M
Q2 24
$61.8M
$-54.0M
Q1 24
$73.2M
$-54.7M
Gross Margin
ABR
ABR
SDGR
SDGR
Q4 25
65.7%
Q3 25
51.6%
Q2 25
47.8%
Q1 25
52.3%
Q4 24
72.6%
Q3 24
50.2%
Q2 24
66.2%
Q1 24
51.6%
Operating Margin
ABR
ABR
SDGR
SDGR
Q4 25
-19.7%
Q3 25
-84.6%
Q2 25
-96.6%
Q1 25
-85.5%
Q4 24
-23.5%
Q3 24
-193.9%
Q2 24
-111.4%
Q1 24
46.9%
-184.3%
Net Margin
ABR
ABR
SDGR
SDGR
Q4 25
37.3%
Q3 25
46.3%
-60.4%
Q2 25
27.8%
-78.8%
Q1 25
32.3%
-100.4%
Q4 24
-45.5%
Q3 24
46.9%
-108.1%
Q2 24
40.4%
-114.2%
Q1 24
45.6%
-149.5%
EPS (diluted)
ABR
ABR
SDGR
SDGR
Q4 25
$0.08
$0.45
Q3 25
$0.20
$-0.45
Q2 25
$0.12
$-0.59
Q1 25
$0.16
$-0.82
Q4 24
$0.31
$-0.55
Q3 24
$0.31
$-0.52
Q2 24
$0.25
$-0.74
Q1 24
$0.31
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABR
ABR
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$482.9M
$395.5M
Total DebtLower is stronger
$11.1B
Stockholders' EquityBook value
$3.0B
$364.1M
Total Assets
$14.5B
$726.2M
Debt / EquityLower = less leverage
3.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABR
ABR
SDGR
SDGR
Q4 25
$482.9M
$395.5M
Q3 25
$423.4M
$391.2M
Q2 25
$255.7M
$450.2M
Q1 25
$308.8M
$500.3M
Q4 24
$503.8M
$352.1M
Q3 24
$687.5M
$388.7M
Q2 24
$737.5M
$377.3M
Q1 24
$908.0M
$431.1M
Total Debt
ABR
ABR
SDGR
SDGR
Q4 25
$11.1B
Q3 25
$10.4B
Q2 25
$10.1B
Q1 25
$9.9B
Q4 24
$10.0B
Q3 24
$10.3B
Q2 24
$10.6B
Q1 24
$11.4B
Stockholders' Equity
ABR
ABR
SDGR
SDGR
Q4 25
$3.0B
$364.1M
Q3 25
$3.0B
$321.4M
Q2 25
$3.0B
$342.9M
Q1 25
$3.0B
$373.5M
Q4 24
$3.0B
$421.4M
Q3 24
$3.0B
$449.4M
Q2 24
$3.1B
$474.0M
Q1 24
$3.1B
$513.7M
Total Assets
ABR
ABR
SDGR
SDGR
Q4 25
$14.5B
$726.2M
Q3 25
$13.9B
$653.7M
Q2 25
$13.6B
$688.2M
Q1 25
$13.4B
$743.0M
Q4 24
$13.5B
$823.2M
Q3 24
$13.9B
$669.3M
Q2 24
$14.2B
$688.4M
Q1 24
$15.1B
$737.8M
Debt / Equity
ABR
ABR
SDGR
SDGR
Q4 25
3.75×
Q3 25
3.47×
Q2 25
3.40×
Q1 25
3.29×
Q4 24
3.29×
Q3 24
3.40×
Q2 24
3.47×
Q1 24
3.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABR
ABR
SDGR
SDGR
Operating Cash FlowLast quarter
$372.4M
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABR
ABR
SDGR
SDGR
Q4 25
$372.4M
$-16.1M
Q3 25
$178.7M
$-61.9M
Q2 25
$60.0M
$-52.2M
Q1 25
$150.5M
$144.1M
Q4 24
$461.5M
$-31.1M
Q3 24
$85.0M
$-33.3M
Q2 24
$69.9M
$-53.7M
Q1 24
$260.0M
$-39.3M
Free Cash Flow
ABR
ABR
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-62.4M
Q2 25
$-52.5M
Q1 25
$143.5M
Q4 24
$-32.0M
Q3 24
$-34.6M
Q2 24
$-54.7M
Q1 24
$-43.4M
FCF Margin
ABR
ABR
SDGR
SDGR
Q4 25
-18.5%
Q3 25
-114.8%
Q2 25
-95.9%
Q1 25
240.9%
Q4 24
-36.2%
Q3 24
-98.0%
Q2 24
-115.6%
Q1 24
-118.5%
Capex Intensity
ABR
ABR
SDGR
SDGR
Q4 25
0.0%
Q3 25
0.9%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
1.0%
Q3 24
3.8%
Q2 24
2.1%
Q1 24
11.2%
Cash Conversion
ABR
ABR
SDGR
SDGR
Q4 25
-0.50×
Q3 25
3.44×
Q2 25
1.65×
Q1 25
3.47×
Q4 24
Q3 24
1.16×
Q2 24
1.13×
Q1 24
3.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABR
ABR

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons